Prevalence and quantification of thoracic pain (TP) through quantitative sensory testing (QST) in patients with chronic interstitial lung disease (cILD)

M. Scherer (Essen, Germany), S. Kampe (Essen, Germany), G. Weinreich (Essen, Germany), U. Costabel (Essen, Germany), F. Bonella (Essen, Germany)

Source: Virtual Congress 2021 – Exercise tolerance, supportive care and more in non-pulmonary fibrosis interstitial lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Scherer (Essen, Germany), S. Kampe (Essen, Germany), G. Weinreich (Essen, Germany), U. Costabel (Essen, Germany), F. Bonella (Essen, Germany). Prevalence and quantification of thoracic pain (TP) through quantitative sensory testing (QST) in patients with chronic interstitial lung disease (cILD). 2343

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The estimation of respiratory muscles (RM) status by echodensitometry in men with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2012 - Various issues in clinical physiology
Year: 2012


The relationship between echodensitometric parameters of respiratory muscles (RM) and indices of body composition (IBC) in men with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2011 - Morphological and functional imaging in obstructive airway disease
Year: 2011


Does tolerance of neuro-muscular electrical stimulation (NMES) relate to gender in patients with an acute exacerbation (AE) of chronic obstructive pulmonary disease (COPD)?
Source: Annual Congress 2012 - Physiotherapy and rehabilitative interventions applied to different populations with respiratory impairment
Year: 2012


Predictive factors for the incidence of lung cancer (LC) complicated in patients with chronic obstructive pulmonary disease (COPD)
Source: International Congress 2019 – Advances in clinical management of COPD
Year: 2019

Prevalence rates of symptoms and diagnoses of chronic bronchitis (CB), emphysema (E) and asthma (A), with or without airflow obstruction (AO), in two Italian general population samples
Source: Eur Respir J 2005; 26: Suppl. 49, 595s
Year: 2005

Benefits of pulmonary rehabilitation (PR) in patients with chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) having the same dyspnoea severity
Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)?
Year: 2018

The use test valsalva manoevre (VM) in diagnosis pulmonary hypertension (PH) for early rehabilitation of patients with lung sarcoidosis (LS)
Source: Eur Respir J 2006; 28: Suppl. 50, 72s
Year: 2006

Effects of an acute exacerbation requiring hospitalisation (AE) on lung function, muscle force and serum IGF-I levels in male patients with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2002; 20: Suppl. 38, 564s
Year: 2002

Quantitative perfusion scintigraphy (QPS) or the anatomic segment method (ASM) for estimating postoperative pulmonary function (PF) in patients treated for non-small cel lung cancer (NSCLC): a retrospective comparison
Source: Annual Congress 2009 - Respiratory mechanics, tissue and cell dysfunction in pulmonary disease
Year: 2009


Pulmonary function response in smokers and patients with chronic obstructive lung disease (COPD) following exposure to concentrated fine (PM2.5) particles
Source: Annual Congress 2009 - Indoor and outdoor air pollution
Year: 2009


Effectiveness of peripheral muscles neuromuscular electrical stimulation (NMES) as the rehabilitation of severe chronic obstructive pulmonary disease (COPD) patients.
Source: International Congress 2018 – What’s hot in rehabilitation in COPD and interstitial lung disease (ILD)?
Year: 2018


A statistical model to estimate lung density (LD) utilizing oscillometry (OS), biometrics (BM), patient reported outcomes (PRO) and pulmonary function tests (PFT)
Source: International Congress 2016 – The future of lung function is beginning now
Year: 2016


Safety of sputum induction (SI) in interstitial lung disease (ILD)
Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease
Year: 2007


Diagnostic value of induced sputum (IS) in interstitial lung disease (ILD)
Source: Annual Congress 2007 - Clinical aspects of interstitial lung disease
Year: 2007


The estimation of respiratory muscles (RM) status by echodensitometry in male patients with acute exacerbation of COPD (AECOPD)
Source: Annual Congress 2010 - Interaction between respiratory and peripheral muscles
Year: 2010


Validation of CAT as an independent assessment tool in pulmonary rehabilitation (PR) for chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2012 - The best posters on quality of life and coping styles in COPD
Year: 2012


The availibility of copd assessment test (CAT) in determination of risk of early hospitalization in chronic obstructive pulmonary disease patients and its correlation with pulmonary function tests, dyspnea measurement scales and St George respiratory questionnaire
Source: International Congress 2014 – COPD markers
Year: 2014


Differential therapy of acute respiratory failure (ARF) in chronic obstructive pulmonary disease (COPD) patients with predominance of emphysema (PE) and predominance of bronchitis (PB)
Source: Eur Respir J 2006; 28: Suppl. 50, 395s
Year: 2006

Pulmonary rehabilitation (PR) exercise tolerance improvement: Differences between interstitial lung disease (ILD) and chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –Exercise, physiotherapy techniques and assessment in different chronic conditions
Year: 2013


Performance of rapid, bedside whole blood C-reactive protein (CRP) test as a diagnostic test for bacterial infection and pneumonia in patients with acute exacerbation of chronic obstructive pulmonary disease (AE COPD)
Source: Eur Respir J 2007; 30: Suppl. 51, 557s
Year: 2007